APOE and Alzheimer disease: Measurement of the brain and CSF levels of docosahexaenoic acid (DHA), an essential ω-3 fatty acid critical for neuronal and brain function [82], revealed that DHA levels are reduced in AD patients [83] and in apoE4 carriers [84], and that apoE4 increases the uptake and incorporation of DHA into distinct brain areas [85].